comparemela.com
Home
Live Updates
NCCN Issues Guideline Update on the Use of High-Dose Methotrexate, Glucarpidase in ALL/B-Cell Lymphoma : comparemela.com
NCCN Issues Guideline Update on the Use of High-Dose Methotrexate, Glucarpidase in ALL/B-Cell Lymphoma
The National Comprehensive Cancer Network has announced a guideline update concerning the treatment of patients with acute lymphoblastic leukemia, B-cell lymphomas, pediatric ALL, and pediatric aggressive mature B-cell lymphoma.
Related Keywords
Ohio
,
United States
,
Cincinnati
,
Laura Ramsey
,
National Comprehensive Cancer Network
,
Cincinnati Children Hospital Medical Center
,
Medical Strategy
,
Cincinnati Children
,
Hospital Medical Center
,
Managing Toxicities
,
Clin Pharmacol
,
Patients With Newly Diagnosed Acute Lymphocytic Leukemia
,
Patients Withb Cell All
,
Nccn
,
High Dose Methotrexate
,
B Cell Lymphomas
,
Pediatric All
,
Glucarpidase
,
comparemela.com © 2020. All Rights Reserved.